Screener
NeoGenomics NEO Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of property and equipment | (13,219) | (10,823) |
| Business acquisition, net of cash acquired | — | (5,991) |
| Purchase of convertible note | (100) | — |
| Net cash used in investing activities | (13,319) | (5,754) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from issuance of convertible debt, net of discount | 305,434 | — |
| Repayment of convertible debt | (262,890) | (201,250) |
| Premiums paid for capped call confirmations | (28,747) | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's investing cash flow?
- NeoGenomics (NEO) reported investing cash flow of -$8.32M in Q2 2026.
- How has NeoGenomics's investing cash flow changed year-over-year?
- NeoGenomics's investing cash flow increased by 10.7% year-over-year, from -$9.31M to -$8.32M.
- What is the long-term trend for NeoGenomics's investing cash flow?
- Over 2 years (2021 to 2025), NeoGenomics's investing cash flow has grown at a -86.0% compound annual growth rate (CAGR), from -$632.37M to -$12.34M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about NeoGenomics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude